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ABSTRACT
Pulmonary alveolar microlithiasis (PAM) is a rare entity, presenting mostly as an incidental finding. This disease has an 
autosomal recessive inheritance with inactivating mutations in the gene “solute carrier family 34 member 2”. The present 
study was conducted to bring attention to this rare though preventable disease. The study was a cross-sectional 
descriptive study, conducted at the Department of Pathology, of a tertiary care hospital in New Dehli-India. PAMs were 
incidentally seen in two patients diagnosed with micronodular hepatic cirrhosis leading to reanalysis of 212 autopsies, 
retrospectively. Statistical analysis was done using Stata 14.0. We observed three forms (Type A, B and C) of round hyaline 
bodies measuring in 200-800µm diameter with thin delicate, radiating fibrils. These bodies were PAS positive, showed 
black discolouration of the pigment with von Kossa stain and birefringence on polarized microscopy using Congo red 
stain, however the refringence was light green as compared to apple green birefringence seen with amyloid deposition. 
PAM has a slow progressive course leading to a high rate of incidental detection. Drugs known to inhibit the micro-crystal 
growth of hydroxyapatite may slow the disease progression. The family members of patients with PAM may also be 
kept on follow up with regular imaging. Key messages: It is important to bring out the incidental finding as, seemingly 
innocuous observations may provide valuable insight into incurable diseases, especially rare diseases. 
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INTRODUCTION
Pulmonary alveolar microlithiasis (PAM) is a 
rare entity, mostly described in early literature as an 
incidental finding. PAM were described as laminated 
bodies in the pulmonary alveoli more than 150 years 
back by Friedreich et al.1 who named them Corpora 
Amylacea Pulmonum. In 1918, these bodies were also 
reported by Norwegian Harbitz who termed it as Harbitz 
syndrome.2 In 1933, Puhr et al.3 coined the entity as 
“pulmonary alveolar microlithiasis” and identified as 
rare autosomal recessive disease with high penetrance 
characterized by intra-alveolar accumulation of 
minute calculi called microliths. Michaelis et al.4 and 
Dobashi et al.5, gave a complete histopathological 
description of these bodies. The microliths are round, 
oval, lobular, concentric and laminated in appearance. 
They vary in diameter from 0.01-2.8mm. PAM are 
periodic acid Schiff (PAS) positive and consist of 
calcareous lamellae around a central nucleus with an 
amorphous or granular aspect. X-ray spectroscopy has 
revealed the composition of the PAM to be calcium 
and phosphate, in a ratio of 2:1.6,7
The disease generally presents in the third or 
fourth decade with mild clinical signs and symptoms 
with chronic and deteriorating evolution. The clinical 
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presentation includes cough, breathlessness, chest 
pain and a lung disorder with restrictive pattern. 
The biochemical investigations are generally normal. 
Imaging may reveal diffuse micronodular calcification 
with sandstorm appearance.8
The precise pathogenesis of PAM is not known; 
however, it is postulated that local accumulation of 
calcium salts might be due to an inborn defect in 
metabolism at alveolar surface leading to increased 
alkalinity or mucopolysaccharide deposition. Another 
hypothesis is that in patients with PAM, the impaired 
mucociliary function may lead to excess mucus 
accumulation within alveoli and condensation of mucus 
may induce the formation of microliths. However, 
PAM is considered to be an autosomal recessive 
disease associated with inactivating mutations in the 
gene “solute carrier family 34 member 2”, encoding 
a sodium-dependent phosphate cotransporter 
(SLC34A2/Npt2b/NaPi-2b), presently. SLC34A2 gene is 
most commonly involved and is located on chromosome 
4p15.2.9-11 The gene is composed of 4122 base pairs 
and 13 Exons. SLC34A2 gene encodes for 2280nt 
mRNA transcript and 690 aminoacids. The gene is 
expressed primarily in alveolar epithelial type II cells 
and is responsible for the uptake of phosphate released 
from phospholipids in outdated surfactant.7
The formation of calcium phosphate microliths 
in PAM could be explained by the inability to clear 
phosphate from the alveolar space. Mutations of the 
SLC34A2 gene are also associated with testicular 
microlithiasis.12 The gene expression is higher in lungs, 
salivary glands, thyroid, kidney, testis, breast and 
female genital tract (endometrium, cervix, uterus). 
It is also expressed in the gastrointestinal tract 
(stomach, small intestine and esophagus) including 
the hepatobiliary system.
The present study was conducted to bring 
attention to this rare, though preventable, entity with 
particular attention to histopathological details, which 
in turn may contribute to a better understanding of 
this rare disease.
SUBJECTS AND METHODS
The study was conducted at the Department of 
Pathology, of a tertiary care hospital, retrospectively. 
Pulmonary alveolar microliths were incidentally found 
in two patients diagnosed with micronodular cirrhosis 
of liver and pulmonary hypertension with extensive 
edema. This finding inspired us to reanalyze all the 
autopsies conducted in the last five years. Two hundred 
and twelve autopsies were reviewed and one more case 
of PAM was identified. Written informed consent had 
already been obtained from next of kin for autopsies. 
Statistical analysis was done using Stata 14.0.
The clinical details of these three cases are 
described below.
Case 1
A 51-year-old male, known case of Type II 
diabetes mellitus, hypertension and a chronic alcohol 
consumer in cirrhogenic doses, presented with fever 
and altered sensorium and yellowish discoloration of 
eyes and urine and myalgia for three days. The patient 
deteriorated showing confusion, aggressive behavior 
and altered sensorium without any motor deficit. 
On investigation, he was found to have deranged 
liver function tests. Chest X-Ray revealed bilateral 
homogenous opacities in the right lung, 2-D echo 
showed left ventricular hypertrophy. USG abdomen 
revealed hepatosplenomegaly with ascites and gall 
bladder wall edema. The patient died with a final 
diagnosis of hepatic encephalopathy.
On autopsy, microbiological examination revealed 
sterile CSF, pleural fluid and peritoneal fluid. Tissue 
samples of lung, myocardium, liver, kidney, pancreas, 
spleen, adrenal glands, stomach and brain, were 
taken for histopathology investigation. On gross 
examination, the lungs were congested and boggy and 
liver was enlarged. The external surface was smooth 
with retained capsular sheen. Rest of the organs were 
normal. The selected specimens were formalin-fixed 
and paraffin-embedded. Sections were cut at three 
micra and stained using the standard H&E and special 
stains such as PAS, MT, reticulin Perl, ZN, van Kossa 
and Congo red were carried out wherever required. 
All slides were examined and photographed on a Nikon 
eclipse Ni microscope.
Sections from the liver showed micro and 
macro-vesicular steatosis. Mild portal and periportal 
infiltrate composed of mononuclear cells was noted 
with a small fibrous expansion of the portal tracts. 
Bilateral kidneys showed mostly normal glomeruli. 
The tubulo-interstitium appeared unremarkable. Blood 
vessels showed intimal proliferation with onion skin 
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appearance in some vessels. Cerebral hemispheres 
showed astrocytic swelling with a prominence of nuclei 
and nucleoli. Pons, medulla, and cerebellum showed 
normal histomorphology. To summarize, the salient 
post-mortem findings included diffuse alveolar edema 
with micro and macrovesicular steatosis and cirrhosis 
of the liver.
Case 2
A 36-year-old male, nonsmoker, chronic alcohol 
consumer, and a known case of acute on chronic 
liver failure, presented with jaundice, reduced 
appetite, and abdominal distension. The patient 
was conscious, well oriented, afebrile with a pulse 
rate of 72 bpm, SPO2-98% with icterus, asterixis, 
and palmar erythema. There was no pallor, edema, 
cyanosis, clubbing or lymphadenopathy. Liver 
function tests were deranged with markedly raised 
bilirubin (26.93mg/dL; reference range [RR]; up to 
1.2mg/dL). He gradually developed cholestatic pruritis 
with conjugated hyperbilirubinemia. He developed 
fever on day five with reduced urine output, hepatic 
encephalopathy and septic shock and was intubated. 
Patient died with a final diagnosis of hepatic 
encephalopathy and septic shock. Microbiological 
examination revealed sterile CSF and peritoneal 
fluid. The pleural fluid showed growth of Klebsiella 
pneumoniae. Tissue samples of lung, myocardium, 
liver, kidney, pancreas, spleen, adrenal glands, 
stomach and brain, were taken for histopathology 
investigation. On gross examination, the lungs were 
congested and boggy. The liver was shrunken with 
micro and macronodular cirrhosis. The remaining 
organs were normal. The selected specimens were 
processed as described for case 1. Sections from the 
liver showed complete effacement of architecture 
with nodules of variable sizes separated by thick 
bridging fibrous septae which were infiltrated by a 
dense lymphocytic inflammatory infiltrate. Bile plugs 
were noted. No ductular proliferation was seen. 
Few degenerated hepatocytes were seen in the 
pools of necrotic cells. The spleen showed features 
of chronic congestive splenomegaly. The kidneys 
maintained the normal architecture; however, the 
glomeruli showed lobular accentuation and the 
tubulointerstitial compartment showed tubular 
necrosis with edematous cytoplasm and mild 
inflammation. Blood vessels appeared normal.
Case 3
A 42-year-old male, nonsmoker, chronic alcoholic 
user and diagnosed with acute on chronic liver failure 
presented with icterus, asterixis and palmar erythema. 
Liver function tests were deranged with markedly raised 
bilirubin (9.2mg/dL; RR; up to 1.2mg/dL). He gradually 
developed cholestatic pruritis with conjugated 
hyperbilirubinemia. He developed fever with reduced 
urine output and hepatic encephalopathy, severe 
hypotension, and septic shock. The patient died with 
a final diagnosis of septic shock with multiorgan 
dysfunction. On autopsy, microbiological examination 
revealed sterile CSF and peritoneal fluid. Escherichia 
coli and Klebsiella pneumoniae were isolated from 
pleural fluid. Tissue samples of lung, myocardium, liver, 
kidney, pancreas, spleen, adrenal glands, stomach and 
brain, were taken for histopathology investigation. 
On gross examination, the lungs were congested 
and boggy. The liver was shrunken and showed the 
presence of micronodules. The remaining organs were 
normal. The selected specimens were processed as 
described for cases 1 and 2.
Sections from the liver showed completely 
effaced architecture by nodules of variable size. 
Regenerating nodules, separated by thick bridging 
fibrous septae, were infiltrated by dense lymphocytic 
inflammatory infiltrate. Bile plugs were noted. 
No ductular proliferation was seen. Few degenerated 
hepatocytes were seen in the pools of necrotic 
cells. Spleen showed features of chronic congestive 
splenomegaly. Renal glomeruli showed lobular 
accentuation. Tubulointerstitial compartment showed 
tubular necrosis with cytoplasmic edematous change 
and mild inflammation. Blood vessels appeared normal.
RESULTS
The microscopic examination from the lungs in 
all the three cases discussed above, revealed round 
or ellipsoid hyaline bodies measuring 200-800µm 
in diameter with thin delicate and radiating fibrils. 
These bodies were detected lying freely in the 
airspace and varied mildly in morphology though 
they may represent the same spectrum. Some of 
these bodies showed a rim of thick hyaline material 
with radiating fibrils terminating before this hyaline 
membrane (Type A, Figure 1A) while others showed 
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Figure 1. Photomicrographs of the lung showing in A - Pulmonary alveolar microlithiasis ‘Type A’; B - Pulmonary 
alveolar microlithiasis ‘Type B’ (A, B - H&E 400X); C - Pulmonary alveolar microlithiasis ‘Type C’ (H&E, 200X); 
D - Congo red stain (400X).
thinner peripheral hyaline membrane with radiating 
fibrils terminating at the edge of hyaline membrane 
(Type B, Figure 1B). The third type was smaller 
(200-250 µm) with fibrils extending till the edge 
(Type C, Figure 1C). Type A bodies showed concentric 
rings with appearance reminiscent of annual layers 
of a tree trunk. These bodies showed finely granular 
pigment at the end of these radiating fibrils. Type 
B bodies also showed yellow pigment though less 
defined. Type ‘B’ and ‘C’ showed the presence of 
refractile material in the core. On polaroid microscopy 
using Congo red stain, PAM showed birefringence, 
however the refringence was light green as compared 
to apple green birefringence seen with amyloid 
deposition (Figure 1D).
Pulmonary alveolar microliths were found to 
be positive for periodic acid Schiff (PAS) (Figure 2A). 
The microliths on von Kossa stain showed a black 
coloration of granular pigment at the end of the 
radiating fibrils (Figure 2B).
Perls stain performed to characterize the refractile 
material in the core excluded the presence of iron. 
Negative Gram and Grocott stain excluded the 
presence of bacterial or fungal elements. Ziehl Neelsen 
stain was performed using 0.5% H2SO4 as decolorizer, 
and ruled out the presence of any acid-fast bacilli 
including members of Nocardiaceae family. PAM were 
seen in the background of varying degree of alveolar 
edema in both lungs. Also, an increase in histiocytic 
activity and focal alveolar septal wall thickening was 
noted. The mild intimal proliferation and medial 
thickening were observed in both arteries and veins. 
No granuloma/thrombi or hyaline membrane formation 
was seen. These differentiated PAM from an infective 
etiology due to the conspicuous absence of any 
inflammatory cells.
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DISCUSSION
In the present study, we endeavored to present 
the histopathological findings of three autopsies in 
which PAM was detected, incidentally. PAM are more 
commonly seen in alveolar spaces as compared to 
metastatic or dystrophic calcification which are more 
common in interstitial or vascular compartment.13 
Previous literature mentioned that corpora amylacea 
pulmonum differs from the PAM since the former 
presents in old-age patients with a lesser density 
of such bodies, which lack calcification. Pulmonary 
alveolar microlithiasis have demonstrated similar 
histomorphological findings as those demonstrated in 
the literature on corpora amylacea pulmonum.14-15 We 
also consider both entities to be part of a spectrum of 
the same disease. In our study, the prevalence of PAM 
was 1.4% as compared to 3.8% in previous literature.4 
Since all the three autopsies had underlying liver 
disease, the association with mutations of SLC34A2 
gene was also explored. There is no association of liver 
disease with mutations of SLC34A2 gene in literature. 
In our subjects, there was no history of consanguinity 
in the families.
In India, this entity was f irst reported by 
Viswanathan et al.14 Very few cases have been reported 
in the literature from different regions of India and less 
than 60 autopsies depicted cases of PAM.16-20
The entity generally has a slowly progressive 
course, leading to a higher rate of incidental 
detection during work-up for other illnesses, or at 
autopsy. There is no specific available treatment. 
Disodium etidronate has also been tried in the dose 
of 10 mg/kg per day orally for as long as one year 
with regression of the calcific densities in some 
studies. It is known to inhibit the microcrystal growth 
of hydroxyapatite. Lung transplantation has been 
performed in a few patients though their long-term 
survival is yet to be proved.21-23
We recommend genetic counseling to the index 
cases’ family members as well as their chest X-ray 
follow-up since the disease shows a familial inheritance 
and the treatment is not easily available, presently. 
On initial presentation, the option to start Disodium 
etidronate for inhibition of the microcrystal growth of 
hydroxyapatite can also be considered.
Written informed consent was obtained from next 
of kin for autopsies.
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